Skip to main content
Caplight Logo









BayVax Biotech Limited

BayVax Biotech Limited

Private
Hong KongHealthcare & Life Scienceshttps://www.bayvaxbio.com/

Last Round

Grant

Jul 1, 2023

Company Overview

BayVax Biotech Limited is a biopharmaceutical company that develops synthetic vaccines and AI-driven computational immunology platforms for treating cancers and immune-related diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Keywords

computational immunologyneoantigen vaccineAI drug discoverygenerative AIpersonalized medicinepeptide vaccineTCR designHLA genotypingin silico drug designbiotech R&Dsenolytic vaccinedrug discovery platformAI-first biotechpharma R&D softwareimmunotherapy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BayVax Biotech Limited Comparables

Compare BayVax Biotech Limited with similar companies based on industry and business-model similarity.

BayVax Biotech Limited comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Deepflare
83%
Synteny
81%
BioLM
81%

BayVax Biotech Limited Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantJul 1, 2023

BayVax Biotech Limited Investors

Notable investors and investment history

BayVax Biotech Limited investors
InvestorRounds
Hong Kong Science and Technology Parks CorporationAccelerator
MiraclePlusAccelerator

BayVax Biotech Limited Filings

Explore SEC and related filing metadata, where available.

BayVax Biotech Limited filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BayVax Biotech Limited's valuation, stock price, and market status.

Is BayVax Biotech Limited a public or private company?

BayVax Biotech Limited is a private company.

What is the current stock price of BayVax Biotech Limited?

BayVax Biotech Limited is a private company with no public stock price. No recent secondary market data is available.

How much is BayVax Biotech Limited worth (valuation)?

Valuation information for BayVax Biotech Limited is not publicly available.

Can I buy BayVax Biotech Limited stock?

BayVax Biotech Limited shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BayVax Biotech Limited's last funding round?

BayVax Biotech Limited's most recent funding round was Grant on July 1, 2023.

Who are the main investors in BayVax Biotech Limited?

Key investors in BayVax Biotech Limited include Hong Kong Science and Technology Park, MiraclePlus.

Will BayVax Biotech Limited IPO soon?

No public IPO plans have been announced for BayVax Biotech Limited.

How can I track BayVax Biotech Limited secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BayVax Biotech Limited's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHong Kong
Year FoundedN/A
Last FundingJul 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?